Table 7.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 1995 to 2004

Recipients with Pancreas After Kidney (PAK) Transplants

  Transplant Year
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Functioning Graft at Discharge 60 98 114 140 207 276 289 338 315 382
With Immunosuppression Info 60 94 113 137 204 275 288 337 312 372
--- + MMF/MPA 0.0% 3.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 5.8% 4.8%
--- + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 1.6%
--- + MMF/MPA + Steroids 0.0% 8.5% 2.7% 1.5% 1.0% 0.0% 0.3% 1.5% 1.6% 1.6%
--- + OtherAntimet 10.0% 1.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
--- + OtherAntimet + Steroids 3.3% 3.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
--- + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.5%
--- + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.3% 0.3%
--- + Steroids 1.7% 3.2% 0.0% 0.7% 2.0% 1.8% 0.3% 0.3% 1.0% 2.7%
CyA 3.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.3% 0.0% 0.0%
CyA + MMF/MPA 1.7% 4.3% 0.0% 0.0% 0.5% 0.0% 0.7% 0.3% 1.0% 1.6%
CyA + MMF/MPA + Steroids 0.0% 20.2% 16.8% 17.5% 10.3% 10.9% 5.6% 7.1% 5.1% 3.2%
CyA + OtherAntimet 23.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
CyA + OtherAntimet + Steroids 1.7% 5.3% 0.0% 1.5% 0.0% 0.0% 0.0% 0.0% 0.3% 0.0%
CyA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.1%
CyA + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.7% 0.5% 1.8% 1.4% 2.1% 1.3% 0.8%
CyA + Steroids 0.0% 2.1% 0.0% 1.5% 0.5% 0.0% 0.0% 0.3% 0.3% 0.8%
Tac 3.3% 3.2% 0.0% 0.0% 7.4% 4.0% 4.5% 5.3% 1.3% 2.7%
Tac + MMF/MPA 5.0% 2.1% 2.7% 0.0% 0.5% 0.0% 0.3% 0.9% 6.4% 8.6%
Tac + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 1.6% 0.8%
Tac + MMF/MPA + Steroids 5.0% 40.4% 66.4% 65.0% 68.1% 67.3% 62.2% 60.2% 59.9% 55.1%
Tac + OtherAntimet 23.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tac + OtherAntimet + Steroids 6.7% 1.1% 0.9% 1.5% 2.0% 1.8% 0.7% 0.3% 0.3% 0.3%
Tac + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.0% 2.4% 2.2% 3.8%
Tac + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.0% 1.0% 5.5% 15.6% 11.3% 6.1% 4.3%
Tac + Steroids 1.7% 1.1% 4.4% 3.6% 2.5% 4.4% 1.0% 2.4% 1.3% 1.9%
Other Regimen 10.0% 1.1% 6.2% 6.6% 3.9% 2.5% 5.9% 4.7% 3.8% 3.5%


Source: OPTN/SRTR Data as of May 2, 2005.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.